PROVIDER PROFILE · NPI 1700880051
Michael Ruggiero
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
2,337
Beneficiaries
—
Total drug cost
$111K
Distinct drugs
71
Brand share
15.1%
Top prescribed drugs
Levothyroxine Sodium151 claims
Atorvastatin Calcium126 claims
Lisinopril105 claims
Amlodipine Besylate101 claims
Omeprazole94 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Michael Ruggiero's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Clinical Pathology Laboratories, Inc. Clinical Laboratory · Austin, TX | 13 | 24 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE